Data / Form D filings / ImmuneBridge Inc.
ImmuneBridge Inc.: Form D filings
ImmuneBridge Inc., a biotechnology company in San Francisco, CA, filed 2 Form D notices with the SEC between 2023 and 2025. The latest, on April 2, 2025, reports $5.6 million sold of a $7.1 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2122 BRYANT ST, San Francisco, CA, 94110
- Phone
- (415) 527-5634
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1960306
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 2, 2025 | New notice | $7,132,000 | $5,632,000 | $1,500,000 | 6 | Mar 24, 2025 | sec.gov |
| Jan 10, 2023 | New notice | $14,150,000 | $10,150,000 | $4,000,000 | 15 | Dec 27, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dylan Alexander Morris | Director | |
| Nadiya Alexander Ishnazarova | Director | |
| Omri Alexander Amirav-Drory | Director | |
| Alicia Alexander Jackson | Director | |
| Stuart Alexander Jacobson | Executive Officer, Director | |
| Thomas Alexander Farrell | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 31, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ImmuneBridge Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.